Alantos Pharmaceuticals

Alantos Pharmaceuticals is a chemically driven biopharmaceutical company. It is committed to the discovery and development of small molecule drugs for osteoarthritis, inflammation, and type II diabetes. Their products include Dipeptidyl and Peptidase IV inhibitors. The company offers various tissue remodeling pathways for rheumatoid arthritis, liver fibrosis, cardiovascular conditions, chronic wound healing, and cancer.